|
인쇄하기
취소
|
Korea's drug pricing controversy
Published: 2006-06-19 06:57:00
Updated: 2006-06-19 06:57:00
Controversy has arisen between the Korean Research-based Pharmaceutical Industry Association (KRPIA) and the Korean government regarding the reform of Korea's national health insurance system and its affects on drug pricing.
Proposal had been made by Korea's Health Ministry to implement a new positive list system.
The system is meant to decrease costs for the national health insurance.
...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.